Physician profile
Caroline A Bobbett
NPI 1063691780
$7,644.38
in general payments reported to CMS, 2019-2025
8 companies · $47.63 in 2025
The $47.63 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,710 · 2020: $250 · 2021: $1,318 · 2022: $1,413 · 2023: $1,846 · 2024: $61.12 · 2025: $47.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,038 · Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,037.50 |
| Food and Beverage | $916.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $3,002.00 | 2019-2023 | |
| Dentsply Sirona INC | $2,494.37 | 2020-2025 | Suresmile, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive, Cerec Tessera |
| Sonendo INC | $1,209.90 | 2019 | |
| Sirona Dental, INC. | $750.00 | 2019 | |
| Ultradent Products INC | $112.99 | 2021 | |
| 3m Company | $47.76 | 2023 | 3m Relyx, Scotchbond Universal Plus, 3m Filtek |
| Solventum Corporation | $14.66 | 2025 | 3m Clinpro, Filtek |
| Nobel Biocare USA | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Bobbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.